Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2. [electronic resource]
Producer: 19920515Description: 7-13 p. digitalISSN:- 0020-7136
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibody Specificity
- Brain Neoplasms -- radiotherapy
- Cell Adhesion Molecules, Neuronal -- immunology
- Extracellular Matrix Proteins -- immunology
- Female
- Glioma -- radiotherapy
- Humans
- Injections, Intralesional
- Iodine Radioisotopes -- therapeutic use
- Male
- Middle Aged
- Neoplasm Proteins -- immunology
- Neoplasm Recurrence, Local -- radiotherapy
- Radioimmunotherapy
- Radiotherapy Dosage
- Tenascin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.